Key result
Microvascular remodelling of subcutaneous resistance arteries acts as an independent predictor of cardiovascular risk in hypertensive patients and may contribute to end-organ damage.
This review highlights that microvascular remodelling in hypertension is not only a structural adaptation but also an independent predictor of cardiovascular risk and a potential target for antihypertensive therapy.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for microvascular-targeted therapy in hypertension; prospective trials needed before clinical adoption.
Feihl et al. (2008) conducted a review in Hypertension. Microvascular remodelling was evaluated. Microvascular remodelling of subcutaneous resistance arteries acts as an independent predictor of cardiovascular risk in hypertensive patients and may contribute to end-organ damage.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: